BridgeBio Pharma BBIO
NASDAQ BBIO
$65.97 -0.64 (-0.96%)
At close: Sep 29, 2026 · 4:00 PM EDT

BridgeBio Pharma (BBIO) Share-based Compensation (2018 - 2026)

Updated

BridgeBio Pharma's Share-based Compensation was $44.07 million in Q2 2026, up 18.3% from $37.24 million a year earlier and up 32.6% from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Share-based Compensation (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, BridgeBio Pharma's Share-based Compensation was $147.22 million through Jun 30, 2026, up 22.3% year-over-year; for FY2025, it came in at $133.02 million, up 38.9% from FY2024.

  • Share-based Compensation shows a five-year compound annual growth rate of 17.9% (FY2020 to FY2025).
  • In earlier years, Share-based Compensation was $95.8 million in FY2024 (-11.9%), $108.71 million in FY2023 (+18.7%), $91.56 million in FY2022 (-8.0%) and $99.51 million in FY2021 (+70.2%).
  • The Q2 2026 figure marks the highest quarterly Share-based Compensation in data going back to Q3 2018.
  • Compared with a year earlier, Share-based Compensation has increased for six straight quarters, with growth averaging 27.3% over the last eight quarters.
  • The best year-over-year quarter for Share-based Compensation over five years was Q2 2025 (growth of 73.6%); the worst was Q1 2022 (a decline of 28.2%).
  • Per Business Quant data, BBIO's Share-based Compensation in the three quarters before Q2 2026 was $33.24 million (Q1 2026), $34.64 million (Q4 2025) and $35.26 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 BridgeBio Pharma 13.01 Bn 10.12 Bn 228.63 Mn 44.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 44.07 Mn
Mar 31, 2026 33.24 Mn
Dec 31, 2025 34.64 Mn
Sep 30, 2025 35.26 Mn
Jun 30, 2025 37.24 Mn
Mar 31, 2025 25.88 Mn
Dec 31, 2024 30.13 Mn
Sep 30, 2024 27.16 Mn
Jun 30, 2024 21.45 Mn
Mar 31, 2024 17.06 Mn
Dec 31, 2023 37.03 Mn
Sep 30, 2023 22.60 Mn
Jun 30, 2023 27.18 Mn
Mar 31, 2023 21.91 Mn
Dec 31, 2022 21.79 Mn
Sep 30, 2022 17.36 Mn
Jun 30, 2022 28.29 Mn
Mar 31, 2022 24.12 Mn
Dec 31, 2021 19.77 Mn
Sep 30, 2021 16.04 Mn
API Access

BridgeBio Pharma Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BBIO&period=max&api_key=YOUR_API_KEY